CNCCentene Corp.

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Sarah M. London

Location

Missouri, USA

Exchange

NYSE

Website

https://centene.com

Summary

Centene Corporation provides programs and services to under-insured and uninsured individuals in the United States.

Company Info

CEO

Sarah M. London

Location

Missouri, USA

Exchange

NYSE

Website

https://centene.com

Summary

Centene Corporation provides programs and services to under-insured and uninsured individuals in the United States.

AI Insights for CNC
5 min read

Quick Summary

Centene Corporation is a U.S.-based managed care company that provides health insurance programs and healthcare services primarily to under-insured and uninsured individuals. The company focuses heavily on government-sponsored healthcare programs, including Medicaid, the Children’s Health Insurance Program, Medicare-Medicaid plans, and long-term services and supports. It also sells individual, small group, and large group commercial healthcare products, including coverage through Affordable Care Act marketplaces. Its main customers are state governments, federal healthcare programs, low-income families, seniors, people with disabilities, foster care populations, and individuals buying subsidized health coverage. Centene operates in the insurance industry and competes by managing medical costs, building provider networks, administering benefits, and offering plans that meet government program requirements.

Strengths

•

Centene’s main strength is its large position in government-sponsored managed care, especially Medicaid and ACA marketplace coverage.

•

The company has significant scale, with tens of thousands of employees and tens of billions of dollars in quarterly revenue, which can help it negotiate provider contracts and spread administrative costs.

•

Its long experience serving low-income, complex, and under-insured populations gives it operational knowledge that is valuable in state Medicaid programs.

•

Centene also benefits from structural demand for subsidized healthcare coverage in the United States, particularly among populations that depend on government programs.

•

Its diversified footprint across Medicaid, Medicare-related programs, and marketplace plans gives it multiple revenue streams, even though many are policy-sensitive.

Key Risks

•

Centene faces major risks from rising medical costs, especially if utilization remains elevated or specialty drug spending continues to grow faster than premiums and reimbursements.

•

Medicaid redeterminations, enrollment shifts, and changes in member acuity can create volatility in revenue and claims experience.

•

The company is also exposed to political and regulatory risk, including changes to ACA subsidies, Medicaid funding, risk adjustment, and state contract requirements.

•

Competitive bidding for Medicaid contracts can pressure margins if states demand lower costs or impose stricter service requirements.

What to Watch

During the most recent reported period in the provided data, Centene showed operating revenue of about $53.58 billion and net income of about $1.09 billion.
Diluted EPS was listed at $2.19, while basic EPS was $2.21, suggesting the company remained profitable in the stated quarter despite broader concerns about cost pressure.
The company’s market capitalization was approximately $33.9 billion, and its price-to-book value was about 1.50, indicating that investors were valuing the company above book value but still with caution.
The broader news backdrop included concerns about rising medical costs, Medicaid shifts, reimbursement pressure, and reduced earnings expectations across managed care.
No major product launch or acquisition was identified in the provided quarter data, so the key event was operational performance and investor reassessment of margin recovery.

Price Drivers

•

Centene’s stock price is being driven primarily by earnings quality, medical cost trends, Medicaid reimbursement, and ACA subsidy expectations.

•

The company has reported large revenue numbers, but investors are focused on whether that revenue can translate into sustainable margins after recent pressure from higher utilization, specialty drug costs, and sicker member populations.

•

Guidance is especially important because recent news described weak profitability, a prior net loss, and 2026 expectations that imply margin recovery must improve.

•

The stock can also react sharply to federal policy decisions, especially whether Congress extends ACA subsidies that support marketplace enrollment.

•

Broader healthcare insurer sentiment also matters, because negative guidance from peers such as Elevance Health and UnitedHealth can signal industrywide cost pressures that affect Centene’s valuation.

Recent News

•

Recent news highlighted that Centene reported very large revenue but also faced significant profitability pressure, including a reported Q4 2025 net loss and a full-year loss.

•

The main causes described were rising medical costs, Medicaid shifts, reimbursement pressure, and margin compression.

•

Other reports suggested that Centene could benefit meaningfully if ACA subsidies are extended, because the company is a major marketplace insurer.

•

Analysts and market commentary have also focused on the company’s health benefit ratio, expense reductions, pharmacy management, and utilization controls.

•

Some news items associated with the ticker term “CNC” discussed CNC machine tools, but those items appear unrelated to Centene Corporation and should not be treated as company-specific Centene news.

Market Trends

•

The broader managed care market is being shaped by higher medical utilization, rising drug costs, government reimbursement pressure, and uncertainty around healthcare policy.

•

Medicaid insurers are facing challenges from changing enrollment patterns, state rate updates, and populations that may be more medically complex after eligibility redeterminations.

•

ACA marketplace insurers are highly sensitive to federal subsidy policy, because subsidies affect both enrollment size and the health profile of insured members.

•

Peer companies such as Elevance Health and UnitedHealth have also reported pressure from higher medical costs, suggesting the issue is industrywide rather than isolated to Centene.

•

At the same time, long-term demand for affordable health coverage remains strong, which gives managed care companies growth potential if they can price plans correctly and control claims costs.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on CNC

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

avatar
@Zalotie 9 months ago

Health insurers facing headwinds from Medicare rates and new PBM regulations

Health insurers facing headwinds from Medicare rates and new PBM regulations

post thumbnail
avatar
@UndyingValue 9 months ago

Market mixed as UnitedHealth tanks the Dow while S&P hits record high

Market mixed as UnitedHealth tanks the Dow while S&P hits record high

post thumbnail

No more topics to show